4: Basic Principles IV Flashcards
______ OF TOXICANTS Can have a widespread influence on drug use by terminating the Effect of a Drug, which is Desirable.
- Route of administration
- Dose
- Effectiveness
- Toxicity, safety
- Duration of effect
BIOTRANSFORMATION OF TOXICANTS Can have a widespread influence on drug use by terminating the Effect of a Drug, which is Desirable
- Route of administration
- Dose
- Effectiveness
- Toxicity, safety
- Duration of effect
Clearance = removal of something from the ______ in ml/min
Clearance = removal of something from the plasma in ml/min
Biotransformation clears drug from the plasma and its rate will depend on endogenous enzyme systems. There are two purposes of biotransformation:
- Drug ______ changes the structure which changes the drug’s intrinsic activity
- Prepare Drug for ______ by reducing the characteristics that made it easy to absorb. i.e., Make drug ______, Add positive or negative ______, Make drug more water ______- especially important- transform drug from lipid soluble form to water soluble form.
Biotransformation clears drug from the plasma and its rate will depend on endogenous enzyme systems. There are two purposes of biotransformation:
- Drug Detoxification changes the structure which changes the drug’s intrinsic activity
- Prepare Drug for Excretion by reducing the characteristics that made it easy to absorb. i.e., Make drug larger, Add positive or negative charges, Make drug more water soluble- especially important- transform drug from lipid soluble form to water soluble form.
Sites of ______ include the liver’s SER, mitochondria, and cytoplasm. It can also occur anywhere else in the body.
Sites of biotransformation include the liver’s SER, mitochondria, and cytoplasm. It can also occur anywhere else in the body.
Liver Microsomal Drug Metabolizing Systems does Both Phase I and Phase II processes of:
Induction: ______ metabolism of the primary drug or other drugs, might be observed as an ______ in first pass metabolism
Inhibition: use a drug to ______ the metabolism of another drug or endogenous compound
Liver Microsomal Drug Metabolizing Systems does Both Phase I and Phase II processes of:
Induction: increase metabolism of the primary drug or other drugs, might be observed as an increase in first pass metabolism
Inhibition: use a drug to block the metabolism of another drug or endogenous compound
Non-microsomal Systems include other organs, plasma, red cells & Usually does Phase I. eg: acetyl cholinesterase, alcohol dehydrogenase.
______ only- intentional or accidental, “polypharmacy”.
Non-microsomal Systems include other organs, plasma, red cells & Usually does Phase I. eg: acetyl cholinesterase, alcohol dehydrogenase.
Inhibition only- intentional or accidental, “polypharmacy”.
What is the most common phase 1 rxn?
Oxidation = the addition of Oxygen
Components of Hepatic Mixed Function ______ System:
- NADPH
- Cytochrome P450 reductase (flavoprotein)
- Cytochrome P450 (hemoproteins)
- Mg++
- Phospholipid
- O2
Usually metabolize ______ soluble drugs
The drug as a [substrate] will concentrate in the ______
Components of Hepatic Mixed Function Oxidase System:
- NADPH
- Cytochrome P450 reductase (flavoprotein)
- Cytochrome P450 (hemoproteins)
- Mg++
- Phospholipid
- O2
Usually metabolize lipid soluble drugs
The drug as a [substrate] will concentrate in the SER (smooth endoplasmic reticulum)
12 P450 groups in humans - some for toxins (drugs) - others for endogenous compounds:
- ______ specificity
- very ______ genetic variations
- catalyzes primarily ______, but does some reductions.
12 P450 groups in humans - some for toxins (drugs) - others for endogenous compounds:
- low specificity
- very large genetic variations
- catalyzes primarily oxidations, but does some reductions.
CYP2D6 has substatian genetic variation.
Phenotypes of patients for metabolic activity
- poor → potential ______
- intermediate
- extensive
- ultrarapid → potential no ______ effect- high first pass metabolism
CYP2D6 has substatian genetic variation.
Phenotypes of patients for metabolic activity
- poor → potential toxicity
- intermediate
- extensive
- ultrarapid → potential no theraputic effect- high first pass metabolism
65 commonly used drugs metabolized by CYP2D6
Potential drug interactions when various drugs are metabolized by the ______ type of cytochrome P450 enzymes - ______ metabolism
- competition with inhibition - potential ______
- Induction → ______ effectiveness for a given dose
cP450 System also influenced by:
A. ______ factors - liver disease, liver perfusion
B. Age and sex - fetal → geriatric
65 commonly used drugs metabolized by CYP2D6
Potential drug interactions when various drugs are metabolized by the same type of cytochrome P450 enzymes - slow metabolism
- competition with inhibition - potential toxicities
- Induction → decrease effectiveness for a given dose
cP450 System also influenced by:
A. Disease factors - liver disease, liver perfusion
B. Age and sex - fetal → geriatric
Types of Drug Biotransformations Carried Out
by Hepatic Mixed Function Oxidase System:
Drug oxidation = add ______
Drug reductions = add ______ or change the proportion of hydrogen in the molecule
Types of Drug Biotransformations Carried Out
by Hepatic Mixed Function Oxidase System:
Drug oxidation = add oxygen
Drug reductions = add Hydrogen or change the proportion of hydrogen in the molecule
PHASE II REACTIONS occur in the ______.
______ = synthesis of a new molecule. Enzymes using endogenous substrates. Covalent bond of drug to another molecule.
As a result of ______, Molecule is: Larger, Charged, Water Soluble, & Inactive.
PHASE II REACTIONS occur in the liver.
Conjugation = synthesis of a new molecule. Enzymes using endogenous substrates. Covalent bond of drug to another molecule.
As a result of conjugation, Molecule is: Larger, Charged, Water Soluble, & Inactive.
______ order enzyme kinetics = concentration of drug is less than Km so = constant x [drug]—velocity is responsive to drug concentration.
______ order enzyme kinetics = v = Vmax & inefficient since it saturated so always working @ Vmax. Velocity is not responsive to drug concentration.
First order enzyme kinetics = concentration of drug is less than Km so = constant x [drug]—velocity is responsive to drug concentration.
Zero order enzyme kinetics = v = Vmax & inefficient since it saturated so always working @ Vmax. Velocity is not responsive to drug concentration.
Concerning hepatic enzymes:
______ = increases metabolism caused by the drug in question or by other drugs.
______ = decreases metabolism caused by another drug.
Concerning hepatic enzymes:
Induction = increases metabolism caused by the drug in question or by other drugs.
Inhibition = decreases metabolism caused by another drug.